Search results for "Factual"

showing 10 items of 359 documents

Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data

2010

SummaryBackgroundLong-term oral corticosteroid (OCS) therapy is associated with significant burden on patients and healthcare resources; treatments that may help reduce their use are important to improve asthma management.MethodsFrench and German clinicians prescribing omalizumab for >16 weeks to patients with severe persistent allergic asthma collected OCS use data. OCS use was recorded at baseline and at a non-specific time point beyond 16 weeks from initiation of omalizumab. The number of asthma exacerbations (FEV1 16 weeks. Of these, 166 (48.0%) were receiving maintenance OCS (France, n = 64; Germany, n = 102). Following omalizumab therapy, 84 (50.6%) patients on OCS at baseline reduced…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyAllergyDatabases Factualmedicine.drug_classAllergic asthmaOmalizumabOmalizumabAntibodies Monoclonal HumanizedImmunoglobulin EAdrenal Cortex HormonesOral administrationGermanyInternal medicineOral corticosteroidsRespiratory HypersensitivityHumansMedicineAnti-Asthmatic AgentsAnti-IgEAsthmabiologybusiness.industryRespiratory diseaseAntibodies MonoclonalMiddle Agedmedicine.diseaseAsthmaAntibodies Anti-IdiotypicSurgeryHospitalizationbiology.proteinPrednisoloneCorticosteroidFemaleFrancebusinessmedicine.drugRespiratory Medicine
researchProduct

A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score.

2009

Recent studies of drug-eluting stents (DES) use in routine clinical practice have led to concern regarding their long-term safety and to questions about the adequacy of current antiplatelet therapy guidelines. This study sought to derivate a risk score for predicting stent thrombosis after drug-eluting stenting. The large single center DES Real-world Incremental Value in the erA of percutaneous revascularizaTION (DERIVATION) database, collecting data about 1,377 patients of any age undergoing PCI with DES as treatment for symptomatic coronary artery disease, was use for this purpose. Logistic regression and bootstrap procedure were used to select correlates of stent thrombosis that were sub…

MaleRiskmedicine.medical_specialtyDatabases Factualmedicine.medical_treatmentRevascularizationCoronary AngiographyPredictive scoreCoronary artery diseaseAngioplastyInternal medicineMedicineHumansProspective StudiesAcute Coronary SyndromeAngioplasty Balloon CoronaryAgedFramingham Risk Scorebusiness.industryStent thrombosis.Percutaneous coronary interventionDrug-Eluting StentsThrombosisGeneral MedicineOdds ratioMiddle Agedmedicine.diseasePrognosisThrombosisLogistic ModelsConventional PCIMultivariate AnalysisCardiologyFemaleRadiologyDrug-eluting stentCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsFollow-Up StudiesForecastingClinical research in cardiology : official journal of the German Cardiac Society
researchProduct

Risk of bleeding related to selective and non-selective serotonergic antidepressants: a case/non-case approach using data from two pharmacovigilance …

2014

There is increasing evidence for an association between treatment with selective serotonin reuptake inhibitors (SSRI) and an increased risk of bleeding events. The most important underlying mechanism appears to be inhibition of serotonin uptake in platelets, an effect that is also present in antidepressants with non-selective serotonin-reuptake inhibition (NSRI). Accordingly, also NSRI may be associated with an increased risk of bleeding. However, there is little data in this regard.Based on data (spontaneous reports of adverse drug reactions) from 2 pharmacovigilance databases (WHO-database/Vigibase™; BfArM/AkdÄ-database in Germany) we used a case/non-case approach and calculated reporting…

MaleSerotonin uptakeDatabases FactualDrug-Related Side Effects and Adverse ReactionsVenlafaxineHemorrhageSerotonergiccomputer.software_genrePharmacovigilanceDiclofenacSerotonin AgentsSerotonin AgentsGermanyPharmacovigilanceMedicineHumansPharmacology (medical)Databasebusiness.industryDepressionGeneral MedicineOdds ratioAntidepressive AgentsPsychiatry and Mental healthFemalebusinessReuptake inhibitorcomputermedicine.drugPharmacopsychiatry
researchProduct

The Art of Helpful Relationships with Professionals: A Meta-ethnography of the Perspective of Persons with Severe Mental Illness.

2015

Relationships with professionals have been shown to be helpful to persons with severe mental illness (SMI) in relation to a variety of services. In this article, we aimed to synthesize the available qualitative research to acquire a deepened understanding of what helpful relationships with professionals consists of, from the perspective of persons with SMI. To do this, we created a meta-ethnography of 21 studies, through which ten themes and an overarching interpretation were created. The findings show that helpful relationships with professionals are relationships where the persons with SMI get to spend time with professionals that they know and trust, who gives them access to resources, s…

MaleSocial workDatabases FactualMental DisordersPerspective (graphical)Patient PreferenceInterpersonal communicationProfessional-Patient RelationsService providerMental illnessmedicine.diseaseVariety (cybernetics)Psychiatry and Mental healthInterpersonal relationshipmedicineHumansFemaleCooperative BehaviorPsychologyPhysician's RoleSocial psychologyQualitative researchThe Psychiatric quarterly
researchProduct

Some findings on zero-inflated and hurdle Poisson models for disease mapping

2018

Zero excess in the study of geographically referenced mortality data sets has been the focus of considerable attention in the literature, with zero-inflation being the most common procedure to handle this lack of fit. Although hurdle models have also been used in disease mapping studies, their use is more rare. We show in this paper that models using particular treatments of zero excesses are often required for achieving appropriate fits in regular mortality studies since, otherwise, geographical units with low expected counts are oversmoothed. However, as also shown, an indiscriminate treatment of zero excess may be unnecessary and has a problematic implementation. In this regard, we find …

MaleStatistics and ProbabilityDatabases FactualEpidemiologyComputer scienceGeographic MappingEstadísticaBiostatisticsPoisson distribution01 natural sciences010104 statistics & probability03 medical and health sciencessymbols.namesakeSpatio-Temporal Analysis0302 clinical medicineNeoplasmsEconometricsHumansPoisson Distribution030212 general & internal medicineLack-of-fit sum of squaresMortality0101 mathematicsProbabilityModels StatisticalBayes TheoremZero (linguistics)SpainMortality datasymbolsMalaltiesFemaleFocus (optics)
researchProduct

Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: A retrospective chart review fr…

2009

Background: Few studies have examined the role of cardiovascular drugs on acute ischaemic stroke prognosis. Aims: To evaluate the relationship between a favourable outcome in patients with acute ischaemic stroke and specific demographic, clinical and laboratory variables and cardiovascular drug pretreatment. Methods: The 1096 patients enrolled in the GIFA study (who had a main discharge diagnosis of ischaemic stroke) represent the final patient sample used in this analysis. Drugs considered in the analysis included angiotensin converting enzyme (ACE)-inhibitors, angiotensin II receptor blockers, statins, calcium channel blockers, anti-platelet drugs, vitamin K antagonists and heparins. The …

MaleStroke prognosis pre-treatmentmedicine.medical_specialtySettore MED/09 - Medicina InternaActivities of daily livingDatabases FactualBrain IschemiaInternal medicineWhite blood cellmedicineHumansHospital MortalityStrokeAgedRetrospective StudiesAged 80 and overbiologybusiness.industryPharmacoepidemiologyCalcium channelCardiovascular AgentsAngiotensin-converting enzymeRetrospective cohort studyHeparinmedicine.diseaseStrokeTreatment Outcomemedicine.anatomical_structureBlood pressureItalybiology.proteinPhysical therapyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up Studiesmedicine.drugInternational Journal of Cardiology
researchProduct

A multicenter 12-month experience with a new iliac side-branched device for revascularization of hypogastric arteries.

2016

Abstract Objective The aim of this study was to investigate the 1-year safety and efficacy of a new iliac side-branched device (IBD) for revascularization of the hypogastric arteries. Methods Patients receiving the E-liac (Jotec GmbH, Hechingen, Germany) side-branched device at six German vascular centers either as a stand-alone procedure or in combination with abdominal aortic aneurysm exclusion were included in a prospectively created data bank. Collected data were analyzed for baseline characteristics, procedural events, and clinical follow-up; variables included endoleaks, reinterventions, and internal iliac artery (IIA) patency. Results Between January 2012 and January 2015, a total of…

MaleTime FactorsDatabases FactualEndoleakComputed Tomography Angiographymedicine.medical_treatmentBlood Loss Surgical030204 cardiovascular system & hematologyEndovascular aneurysm repair030218 nuclear medicine & medical imaging0302 clinical medicineRisk FactorsGermanyMedicineHospital MortalityAged 80 and overEndovascular ProceduresGraft Occlusion VascularArteriesMiddle AgedCommon iliac arteryInternal iliac arteryAbdominal aortic aneurysmTreatment OutcomeIliac AneurysmFemaleStentsRadiologyCardiology and Cardiovascular Medicinemedicine.medical_specialtyRevascularizationProsthesis DesignPelvis03 medical and health sciencesBlood Vessel Prosthesis ImplantationAneurysmBlood vessel prosthesismedicine.arteryHumansVascular PatencyAgedRetrospective Studiesbusiness.industryExternal iliac arteryAngiography Digital Subtractionmedicine.diseaseSurgeryBlood Vessel ProsthesisFeasibility StudiesSurgerybusinessJournal of vascular surgery
researchProduct

Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal V…

2014

Background: Approximately 10-20% of recurrences in patients treated with nephrectomy for renal cell carcinoma (RCC) develop beyond 5 yr after surgery (late recurrence). Objective: To determine features associated with late recurrence. Design, setting, and participants: A total of 5009 patients from a multicenter database comprising 13 107 RCC patients treated surgically had a minimum recurrence-free survival of 60 mo (median follow-up [FU]: 105 mo [range: 78-135]); at last FU, 4699 were disease free (median FU: 103 mo [range: 78-134]), and 310 patients (6.2%) experienced disease recurrence (median FU: 120 mo [range: 93-149]). Interventions: Patients underwent radical nephrectomy or nephron-…

MaleTime FactorsDatabases FactualLymphovascular invasionmedicine.medical_treatmentPredictive Value of Testcomputer.software_genreNephrectomyRisk modelDecision Support TechniqueRisk FactorsRetrospective StudieRenal cell carcinomaOdds Ratiolate recurrencenephrectomyMedicineMultivariate AnalysiFramingham Risk ScoreDatabaseKidney Neoplasmrenal carcinomaPrognostic parametersMiddle AgedNephrectomyKidney NeoplasmsTreatment OutcomeLymphatic MetastasisFemaleRadiologyNephron sparing surgeryPrognostic parameterHumanmedicine.medical_specialtyrenal cell carcinomarecurrenceLogistic ModelTime FactorUrologyReproducibility of ResultLate recurrencecancer-specific mortalityrisk scoreRisk AssessmentDisease-Free SurvivalDecision Support Techniquescancer-specific mortality; late recurrence; nephrectomy; prognostic parameters; renal cell carcinoma; risk scorePredictive Value of TestsLate RecurrenceHumansInternal validationCarcinoma Renal CellProportional Hazards ModelsRetrospective StudiesAgedNeoplasm StagingChi-Square Distributionbusiness.industryProportional hazards modelRisk Factorrenal cell carcinoma; recurrence; Cancer-specific mortality; Late recurrence; Nephrectomy; Prognostic parameters; Risk scoreCancer-specific mortalityReproducibility of ResultsLymphatic MetastasiRetrospective cohort studyOdds ratioprognostic parametersmedicine.diseaseConfidence intervalLogistic ModelsMultivariate AnalysisProportional Hazards ModelRisk scoreNeoplasm GradingNeoplasm Recurrence LocalbusinesscomputerCancer-specific mortality; Late recurrence; Nephrectomy; Prognostic parameters; Renal cell carcinoma; Risk score
researchProduct

Intensive care unit strain should not rush physicians into making inappropriate decisions, but merely reduce the time to the right decisions being ma…

2016

The effect of capacity strain in an ICU on the timing of end-of-life decision-making is unknown. We sought to determine how changes in strain impact timing of new do-not-resuscitate (DNR) orders and of death.Retrospective cohort study of 9891 patients dying in the hospital following an ICU stay ≥72 h in Project IMPACT, 2001-2008. We examined the effect of ICU capacity strain (measured by standardized census, proportion of new admissions, and average patient acuity) on time to initiation of DNR orders and time to death for all ICU decedents using fixed-effects linear regression.Increases in strain were associated with shorter time to DNR for patients with limitations in therapy (predicted ti…

MaleTime FactorsDatabases Factualcommunication strategySeverity of Illness Indexlaw.invention0302 clinical medicinelawicuVasoconstrictor Agents030212 general & internal medicineHospital MortalityComputingMilieux_MISCELLANEOUSmedia_commonResuscitation OrdersAged 80 and overTerminal CaresupportGeneral MedicineMiddle AgedIntensive care unit3. Good healthIntensive Care UnitsEditorialqualityFemaleMedical emergencyof-life practicesAutonomyAdultmedicine.medical_specialtymedia_common.quotation_subjectCritical IllnessDecision Making03 medical and health sciencesQuality of life (healthcare)[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologymedicineendHumansQuality (business)surrogateIntensive care medicineAgedRetrospective Studiescapacity strainbusiness.industry030208 emergency & critical care medicinefamily membersLength of Staymedicine.diseaseRespiration ArtificialcultureLinear Modelsbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

A 15-Year Single-Center Experience of Endovascular Repair for Elective and Ruptured Abdominal Aortic Aneurysms

2016

Purpose: To evaluate the differences in technical outcomes and secondary interventions between elective endovascular aneurysm repair (el-EVAR) procedures and those for ruptured aneurysms (r-EVAR). Methods: Of the 906 patients treated with primary EVAR from September 1998 until July 2012, 43 cases were excluded owing to the use of first-generation stent-grafts. Among the remaining 863 patients, 773 (89.6%) patients (mean age 72 years; 697 men) with asymptomatic or symptomatic abdominal aortic aneurysms (AAAs) were assigned to the el-EVAR group; 90 (10.4%) patients (mean age 73 years; 73 men) were assigned to the r-EVAR group based on blood outside the aortic wall on preoperative imaging. Th…

MaleTime FactorsDatabases Factualmedicine.medical_treatmentKaplan-Meier Estimate030204 cardiovascular system & hematologySingle CenterEndovascular aneurysm repairendovascular aneurysm repairPostoperative Complications0302 clinical medicineRisk Factors030212 general & internal medicineNetherlandsAged 80 and overmedicine.diagnostic_testruptured aneurysmEndovascular ProceduresMiddle AgedAbdominal aortic aneurysmTreatment OutcomeElective Surgical ProceduresreinterventionsFemaleStentsmedicine.symptomCardiology and Cardiovascular Medicinemedicine.medical_specialtyAortographycomplicationsAortic RuptureendoleakProsthesis DesignAortographyAsymptomaticDisease-Free SurvivalBlood Vessel Prosthesis Implantation03 medical and health sciencesabdominal aortic aneurysmBlood vessel prosthesismedicineHumansRadiology Nuclear Medicine and imagingAortic ruptureAgedRetrospective Studiesstent-graftbusiness.industryRetrospective cohort studymedicine.diseaseBlood Vessel ProsthesisSurgerySurgeryEmergenciesbusinessAortic Aneurysm AbdominalJournal of Endovascular Therapy
researchProduct